Innovation Pharmaceuticals Inc (IPIX)

[Rdunn88]

All boils down to whether B is more effective than current treatments with possibly needing an expensive phase 3. Prime example was Absssi, even though many believe the trial was a success because they met their endpoints it never advanced due to revenue potential versus phase 3 expenses... Why Leo continues the development chatter in press releases and shareholder alerts... Nobody gives a damn about developing B for 2035... All the hype should be directed at emergency use and finding a partner for a quick as possible phase 3... The PPS shares the sentiment...